SCHEMBL7947656

SCHEMBL7947656

CCCC[C@@H](C)C(=O)OC

nearest known ligand 0.61

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CA1 P00915 6/20 0.61
CA2 P00918 6/20 0.61
ZDHHC7 Q9NXF8 1/20 0.52
ABCB1 P08183 1/20 0.44
BIRC2 Q13490 2/20 0.41
FDPS P14324 1/20 0.41
SLC15A1 P46059 1/20 0.41
CYP3A4 P08684 1/20 0.40
TSHR P16473 1/20 0.40
ATM Q13315 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
MAPK1 P28482 1/20 0.40
ACE2 Q9BYF1 1/20 0.39
MAPT P10636 1/20 0.39
HSD17B10 Q99714 1/20 0.39
USP2 O75604 1/20 0.39
LMNA P02545 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11298047 1.00 CA1 (0.61) CA1CA2ZDHHC7ABCB1BIRC2
SCHEMBL2779851 1.00 CA1 (0.61) CA1CA2ZDHHC7ABCB1BIRC2
SCHEMBL28452311 0.98 CA1 (0.59) CA1CA2ZDHHC7ABCB1BIRC2
Iodide SCHEMBL2220838 0.98 CA1 (0.59) CA1CA2ZDHHC7ABCB1BIRC2
Ethane SCHEMBL28291164 0.98 CA1 (0.59) CA1CA2ZDHHC7ABCB1BIRC2
SCHEMBL6054956 0.98 CA1 (0.59) CA1CA2ZDHHC7ABCB1BIRC2
SCHEMBL5529335 0.93 ZDHHC7 (0.60) CA1CA2ZDHHC7ABCB1BIRC2
SCHEMBL3682137 0.93 ZDHHC7 (0.60) CA1CA2ZDHHC7ABCB1BIRC2
SCHEMBL16575041 0.93 ZDHHC7 (0.60) CA1CA2ZDHHC7ABCB1BIRC2
SCHEMBL560716 0.91 ZDHHC7 (0.63) CA1CA2ZDHHC7ABCB1BIRC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130137667-A1 LIGANDS FOR NEMATODE NUCLEAR RECEPTORS AND USES THEREOF Board of Regents, Univesity of Texas System (US) 2013-05-30 US disclosed
US-6265440-B1 STOMACH ULCERS R-TECH UENO, LTD. (JP) 2001-07-24 US disclosed
US-5886034-A ANTIULCER AGENTS KABUSHIKI KAISHA UENO SEIYAKU KENKYUJO (JP) 1999-03-23 US disclosed
US-5428062-A Side effect reduction K.K. UENO SEIYAKU OYO KENKYUJO (JP) 1995-06-27 US disclosed
US-5380709-A Prostaglandins E and anti ulcers containing same K.K. UENO SEIYAKU OYO KENKYUJO (JP) 1995-01-10 US disclosed
US-5284858-A Prostaglandins E and anti ulcers containing same KABUSHIKI KAISHA UENO SEIYAKU OYO KENKYUJO (JP) 1994-02-08 US disclosed
US-5225439-A Side effect reduction K.K. UENO SEIYAKU OYO KENKYUJO (JP) 1993-07-06 US disclosed
US-5166174-A For duodenal ulcers or gastric ulcers K.K. UENO SEIYAKU OYO KENKYUJO (JP) 1992-11-24 US disclosed
EP-0284180-B1 PROSTAGLANDINS E AND ANTI ULCERS CONTAINING SAME Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo (JP) 1992-08-19 EP disclosed
EP-0284180-A1 Prostaglandins E and anti ulcers containing same Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo (JP) 1988-09-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130137667-A1 LIGANDS FOR NEMATODE NUCLEAR RECEPTORS AND USES THEREOF NR4A1, NR0B1, NR1H2 CA1 4722/4885CA2 3508/4885ZDHHC7 2657/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.